Cargando…
Bioengineering of Tobacco Mosaic Virus to Create a Non-Infectious Positive Control for Ebola Diagnostic Assays
The 2014 Ebola epidemic is the largest to date. There is no cure or treatment for this deadly disease; therefore there is an urgent need to develop new diagnostics to accurately detect Ebola. Current RT-PCR assays lack sensitive and reliable positive controls. To address this critical need, we devis...
Autores principales: | Lam, Patricia, Gulati, Neetu M., Stewart, Phoebe L., Keri, Ruth A., Steinmetz, Nicole F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814824/ https://www.ncbi.nlm.nih.gov/pubmed/27030058 http://dx.doi.org/10.1038/srep23803 |
Ejemplares similares
-
Nanomanufacturing of Tobacco Mosaic Virus-Based Spherical
Biomaterials Using a Continuous Flow Method
por: Bruckman, Michael A., et al.
Publicado: (2014) -
Tobacco mosaic virus for the targeted delivery of drugs to cells expressing prostate-specific membrane antigen
por: Shukla, Sourabh, et al.
Publicado: (2021) -
Sequence optimized diagnostic assay for Ebola virus detection
por: Koehler, Jeffrey W., et al.
Publicado: (2023) -
ON THE MUTATION OF THE TOBACCO MOSAIC VIRUS
por: Opatowski, I.
Publicado: (1949) -
Infectious Disease Diagnostic Assays
por: Lappin, Michael R.
Publicado: (2009)